Genetic landscape of pediatric Retinoblastoma
Retinoblastoma is a pediatric cancer of the developing retina. All retinoblastomas are believed to initiate with biallelic inactivation of the RB1 gene. To identify subsequent genetic lesions in retinoblastoma, we performed whole genome sequencing of tumor and normal DNA of 4 children with retinoblastoma and one matched orthotopic xenograft. Both alleles of RB1 were inactivated in the tumor samples. 3 of the patients had sporadic retinoblastoma and one patient had inherited retinoblastoma. Overall, there were few single nucleotide changes in coding regions of the genome and some of the tumors had few chromosomal lesions. There were very few new genetic lesions in the xenograft compared to the primary tumor. These data suggest that the genome in retinoblastoma is more stable than previously believed and there are relatively few recurrent genetic lesions in known cancer pathways other than the RB1 pathway.
- Type: Whole Genome Sequencing
- Archiver: European Genome-phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD00001000261 | Illumina HiSeq 2000 | 8 | |
| EGAD00001001352 | Illumina HiSeq 2000 | 38 | |
| EGAD00001001432 | Illumina HiSeq 2000 | 1337 |
| Publications | Citations |
|---|---|
|
A novel retinoblastoma therapy from genomic and epigenetic analyses.
Nature 481: 2012 329-334 |
388 |
|
Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing data.
Genome Biol 13: 2012 R113 |
29 |
|
The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities.
Dev Biol 411: 2016 287-293 |
64 |
|
The landscape of coding RNA editing events in pediatric cancer.
BMC Cancer 21: 2021 1233 |
10 |
|
Comprehensive analysis of mutational signatures reveals distinct patterns and molecular processes across 27 pediatric cancers.
Nat Cancer 4: 2023 276-289 |
66 |
|
A pathway-informed mutual exclusivity framework to detect genetic interactions in pediatric cancer.
BMC Med Genomics 19: 2025 14 |
0 |
